GridAI Technologies (GRDX) Gross Margin (2026)
GridAI Technologies' (GRDX) quarterly Gross Margin came in at 42.52% in Q2 2026.
Powered by 
Analysis
GridAI Technologies (GRDX) Gross Margin (2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Gross Margin for 1 consecutive years, with 42.52% the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.73 Bn | 192.74 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 179.91 Bn | 176.73 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.48 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 82.13 Bn | 74.13 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 53.70 Bn | 48.56 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 33.05 Bn | 29.74 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | 71.60% |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | 80.31% |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | -42.52% |